ArticleNeuro-oncology2021

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).

Hussein A Tawbi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.